Increased production of inflammatory cytokines in mild cognitive impairment. - Wikidata - awgldk - TriplyDB

Increased production of inflammatory cytokines in mild cognitive impairment.

Increased production of inflammatory cytokines in mild cognitive impairment.

http://www.wikidata.org/entity/Q35792619

about

Diet and Alzheimer’s disease risk factors or prevention: the current evidence Dietary interventions for prevention of dementia in people with mild cognitive impairment The role of macrophage migration inhibitory factor in Alzheimer's disease Cerebrospinal fluid and blood biomarkers in Alzheimer's disease Identification of a 5-protein biomarker molecular signature for predicting Alzheimer's disease Inflammatory Biomarkers and Cognitive Decline: The Ginkgo Evaluation of Memory Study.Alterations in the inflammatory cytokines and brain-derived neurotrophic factor contribute to depression-like phenotype after spared nerve injury: improvement by ketamine.Ginkgo biloba extract in Alzheimer's disease: from action mechanisms to medical practice.Peripheral inflammatory markers in amnestic mild cognitive impairment Differential expression of cytokines in breast cancer patients receiving different chemotherapies: implications for cognitive impairment research.Multiple cytokines are involved in the early events leading to the Alzheimer's disease pathology Peripheral chemo-cytokine profiles in Alzheimer's and Parkinson's diseases Some hormone, cytokine and chemokine levels that change across lifespan vary by cognitive status in male Fischer 344 rats Proteogenomics of synaptosomal mitochondrial oxidative stress.Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.Cognitive dysfunction with aging and the role of inflammation Daily exercise improves memory, stimulates hippocampal neurogenesis and modulates immune and neuroimmune cytokines in aging rats.Expression profiles of cytokines in the brains of Alzheimer's disease (AD) patients compared to the brains of non-demented patients with and without increasing AD pathology.Mediterranean diet and mild cognitive impairment.Relation between aerobic fitness and brain structures in amnestic mild cognitive impairment elderly.Body mass index, inflammatory biomarkers and neurocognitive impairment in HIV-infected persons.Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.Targeting Tumor Necrosis Factor Alpha for Alzheimer's Disease.Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease.Inflammatory Markers in Mild Cognitive Impairment: A Meta-Analysis.There is no correlation between peripheral inflammation and cognitive status at diagnosis in Alzheimer's disease.Cognitive function and endogenous cytokine levels in children with chronic hepatitis C.Chronic lipopolysaccharide exposure induces cognitive dysfunction without affecting BDNF expression in the rat hippocampus.Executive functioning and diabetes: The role of anxious arousal and inflammation.Adenosine A(2A) Receptor and IL-10 in Peripheral Blood Mononuclear Cells of Patients with Mild Cognitive Impairment.Raised IL-2 and TNF-α concentrations are associated with postoperative delirium in patients undergoing coronary-artery bypass graft surgery.Levels of amyloid beta-42, interleukin-6 and tumor necrosis factor-alpha in Alzheimer's disease and vascular dementia.Cytokine Gene Polymorphisms Associated With Symptom Clusters in Oncology Patients Undergoing Radiation Therapy.Peripheral inflammation in prodromal Alzheimer's and Lewy body dementias.Mild cognitive impairment with associated inflammatory and cortisol alterations as independent risk factor for postoperative delirium.Glycerophospholipid Supplementation as a Potential Intervention for Supporting Cerebral Structure in Older Adults.Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.Effect of Edible Bird's Nest Extract on Lipopolysaccharide-Induced Impairment of Learning and Memory in Wistar Rats Differential chemokine expression under the control of peripheral blood mononuclear cells issued from Alzheimer's patients in a human blood brain barrier model

P2860

Q22241476-E6A800D7-E8C9-45F5-A39C-E93CE65B2082 Q24186832-E9F0476B-78DF-426B-AB24-91B3B23461A3 Q24634765-0D907BA9-2B8A-4CA0-B34D-7A2662028274 Q27023758-5EB6644C-88A9-4BE6-950F-553C84384924 Q28473545-ECEE75B8-1AF5-4D21-B8FC-28F37AC6EB4F Q30276553-4E137DA7-1C0C-4AFC-BB8B-B7A5E8CF9A40 Q30855337-EF225AF9-687B-4D2F-B2F0-363F1D41150C Q33649197-4210AD10-8C3E-4D16-84A8-AF03264B2E92 Q34548819-3CE4F70E-AC55-42C1-B0A2-01C20C820E6A Q35556085-880904B1-C254-424F-90CC-FAB694EC70D0 Q35954373-E94ACBCA-B1FB-4541-B665-F11B7230303F Q36023238-12600A33-86EE-4F29-9C67-9CC519CF6FF5 Q36052866-28817ECB-7C22-4A88-97BF-774C93C852FA Q36215789-75EAD676-3D32-43B4-A7EF-A7DD3E572AE0 Q36420162-78827EF6-0F97-4984-A30D-867B19AA0C94 Q36443732-28F6E092-79AA-4BA8-9D1F-86B83967CF5E Q36532908-0D5262D3-EE26-40A3-86E8-E01B838BFB90 Q36611451-EF75964F-3DCE-435B-8885-A97AE7102989 Q37121952-3F3B889E-422E-4C2A-B3E6-66EC43C4CC87 Q37219603-D6740633-5140-4923-8BA6-6370004C8DEC Q37520967-6868F55F-EAB3-482A-8302-5DA9B5E1BD41 Q38828830-0E1740E1-DFF4-427B-BF84-F83D1FBF2D8C Q38970893-B45F0A63-D92B-453A-A620-2013FB19C94C Q39023028-408320D4-9D09-41D5-B789-7BD4DD22825A Q40507310-43BF9B40-22C0-40CA-AA39-361BBE213012 Q41381108-B6683E68-68C2-480B-8F38-4EBC25913E1D Q41605494-666367F1-FA44-48B8-97B4-F252B6F90055 Q41942395-111FB1BA-825B-4F32-BA44-B9EE495392F7 Q42601475-4586F13C-7151-4453-AF57-4D1B18ED0EB7 Q42738860-F0E605BB-D169-475F-950E-DBE0C0BA8617 Q44291813-697367C4-F048-4506-9CE5-A638B043506E Q44884500-F1AA1866-F229-4C9E-AFE8-35071DC3009A Q46186348-50A94BEC-826D-46D3-AED9-27C4460342D1 Q47284845-3333D6AB-EF5D-4555-A853-AE484598B960 Q50713652-A93E15A4-80EB-44E6-9C78-8BCCB7EE0381 Q51760765-46E01BF0-64E2-4FB3-A212-1289584330F1 Q55380454-9F0EDCD9-7A8D-4BF2-AACC-59E00BB5F6E0 Q58780521-DF234D56-9F21-4432-900B-F90CE7613802 Q58794404-576DF55E-1B21-47A3-934D-A843A6EAA720

P2860

Increased production of inflammatory cytokines in mild cognitive impairment.

http://www.wikidata.org/entity/Q35792619

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

2006年论文

@zh

2006年论文

@zh-cn

name

Increased production of inflammatory cytokines in mild cognitive impairment.

@ast

Increased production of inflammatory cytokines in mild cognitive impairment.

@en

type

label

Increased production of inflammatory cytokines in mild cognitive impairment.

@ast

Increased production of inflammatory cytokines in mild cognitive impairment.

@en

prefLabel

Increased production of inflammatory cytokines in mild cognitive impairment.

@ast

Increased production of inflammatory cytokines in mild cognitive impairment.

@en

P1433

Q35792619-7EDE09E0-5A6F-4984-9E6C-3C5E41C93D0C

P1476

Q35792619-454B206F-3B55-4A1F-8DCA-B98F836A8DD1

P2093

Q35792619-11B03310-3553-4293-8405-7678720B7EB0

Q35792619-AD8D68AD-B39A-4140-879C-6247E5DEBA6C

Q35792619-D7E17EB6-3892-4A58-A356-52E6B9440D8B

Q35792619-DD6E8461-695D-4278-B1F4-28B03D237C16

P2860

Q35792619-0311B5BA-D245-4568-8946-4BB97C0E380C

Q35792619-056EB527-9FA1-4553-91D2-2FB06A932FE0

Q35792619-08475FF7-AF80-4780-88E2-72C62B9696EA

Q35792619-0D19F9AE-ED05-4665-8840-B4303FAA65B3

Q35792619-1BAAFDF8-76DC-4B26-B97C-8202C9EEBDA0

Q35792619-1F31657E-2D2D-48A7-95FE-64B233D52B72

Q35792619-32A5ABFC-725D-416A-AF2E-6F4BFA81E46B

Q35792619-32C9787D-FC18-4668-AE8C-B8BFA29C8D5B

Q35792619-351090B5-1A65-4D1E-AE86-C4343C5855CC

Q35792619-3B790634-9E31-4597-9AF8-00739629142D

P304

Q35792619-F145AA0B-A7AA-473B-A157-12B996C2E992

P31

Q35792619-27628CF0-9637-4AE3-A984-C6A1AB55EFF4

P356

Q35792619-2DEFA2B9-1795-4AFD-8556-5EB330F75AFC

P433

Q35792619-3F8B38C9-1DEF-431F-8492-0311C0B588DC

P478

Q35792619-04AB1C40-6F62-4D79-8F6C-053D70BF54D6

P577

Q35792619-0FB0D092-705D-4E44-85CD-0797B4CE7565

P5875

Q35792619-F3425FED-8960-4E42-A194-D27912287ADE

P698

Q35792619-BBE2F8B2-B804-4AF5-B76C-F1028B95E7B2

P921

Q35792619-2DC9C492-6AEE-4A5E-A65E-FD979D4FFCE0

P932

Q35792619-A8EDDFC1-FBF5-442C-950B-53DF996307A4

P356

J.EXGER.2006.09.015

P1433

Experimental Gerontology

P1476

Increased production of inflammatory cytokines in mild cognitive impairment.

@en

P2093

Cindy Dickson

http://www.w3.org/2001/XMLSchema#string

Claudius Mueller

http://www.w3.org/2001/XMLSchema#string

Shino Magaki

http://www.w3.org/2001/XMLSchema#string

Wolff Kirsch

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-10 and the interleukin-10 receptor

Inflammation and Alzheimer's disease

Mild cognitive impairment as a diagnostic entity

Human antibodies reactive with beta-amyloid protein in Alzheimer's disease

Central beta-amyloid peptide-induced peripheral interleukin-6 responses in mice.

Serum MCP-1 levels are increased in mild cognitive impairment and mild Alzheimer's disease.

Intrathecal chemokine synthesis in mild cognitive impairment and Alzheimer disease.

Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease

Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells.

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

P304

233-240

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.EXGER.2006.09.015

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

2006-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6712108

http://www.w3.org/2001/XMLSchema#string

P698

17085001

http://www.w3.org/2001/XMLSchema#string

P921

P932

1868444

http://www.w3.org/2001/XMLSchema#string